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Review Article
Biopsychosocial predictors of sexual function and quality of 
sexual life: a study among patients with colorectal cancer
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1Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The 
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Objective: A low sexual function (SF) has been reported in patients with colorectal cancer. However, research 
often focusses on clinical predictors of SF, hereby omitting patients’ subjective evaluation of SF [i.e., the quality 
of sexual life (QoSL)] and psychosocial predictors of SF and QoSL. In addition, research incorporating a 
biopsychosocial approach to SF and QoSL is scarce. Therefore, this study aimed to evaluate (I) relatedness 
between SF and the QoSL, (II) the course of SF and QoSL, and (III) biopsychosocial predictors of SF and QoSL.
Methods: Patients completed questionnaires assessing sociodemographic factors (i.e., age, sex) and 
personality characteristics (i.e., neuroticism, trait anxiety) before surgery. Questionnaires assessing 
psychological (i.e., anxious and depressive symptoms, body image, fatigue) and social (i.e., sexual activity, 
SF, non-sensuality, avoidance of sexual activity, non-communication, relationship function) aspects were 
measured preoperative and 3, 6, and 12 months after surgery. Clinical characteristics were obtained from 
the Eindhoven Cancer Registry (ECR). Bivariate correlations evaluated relatedness between SF and QoSL. 
Linear mixed-effects models examined biopsychosocial predictors of SF and QoSL.
Results: SF and QoSL are related constructs (r=0.206 to 0.642). Compared to preoperative scores, SF did 
not change over time (P>0.05). Overall, patients’ QoSL decreased postoperatively (P=0.001). A higher age 
(β=−0.02, P=0.006), fatigue (β=−0.02, P=0.034), not being sexually active (β=−0.081, P<0.001), and having 
a stoma (β=0.37, P=0.035) contributed to a lower SF. Having rectal cancer (β=−1.64, P=0.003), depressive 
symptoms (β=−0.09, P=0.001), lower SF (β=1.05, P<0.001), and more relationship maladjustment (β=−0.05, 
P=0.027) contributed to a lower QoSL (P<0.05). In addition, partners’ SF (β=0.24, P<0.001) and QoSL 
(β=0.30, P<0.001) were predictive for patients’ SF and QoSL, respectively. A significant interaction between 
time and gender was reported for both outcomes (P’s=0.002).
Conclusions: SF and QoSL are related but distinctive constructs. The course of SF and QoSL differed. 
Different biopsychosocial predictors were found for SF and QoSL. The contribution of partner-related 
variables to patients’ outcomes suggests interdependence between patients and partners. Men and women 
showed different SF and QoSL trajectories. We recommend that health care professionals, when discussing 
sexuality, realize that SF and QoSL are no interchangeable terms and should, therefore, be discussed as 
two separate entities. In addition, it is favored that clinicians focus not only on biological predictors of SF 
and QoSL, but obtain a broader perspective in which they also pay attention to psychosocial factors that 
may impair SF and QoSL. More in depth research on interdependence between patients and partners, 
biopsychosocial predictors of partners’ SF and QoSL, and gender effects is needed.
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Introduction
Oncological research primarily focuses on developing and 
implementing treatments that increase overall and disease-
free survival. For colorectal cancer, the introduction of the 
total mesorectal excision procedure and the development 
of effective (neo)adjuvant treatments are important 
contributions in this regard (1,2). Due to the increased life 
expectancy for patients with colorectal cancer, more awareness 
arose for the potential side-effects of treatments and patients’ 
quality of life. Quality of life is a multi-dimensional construct, 
incorporating at least physical, psychological, and social 
well-being (3). Sexuality is considered central to a person’s 
well-being and is, as such, an important aspect of quality of 
life (4). However, sexuality itself is a broad concept as can 
be seen in the World Health Organization’s definition of 
sexuality: “…a central aspect of being human throughout 
life encompasses sex, gender identities and roles, sexual 
orientation, eroticism, pleasure, intimacy and reproduction. 
Sexuality is experienced and expressed in thoughts, 
fantasies, desires, beliefs, attitudes, values, behaviours, 
practices, roles and relationships. While sexuality can 
include all of these dimensions, not all of them are always 
experienced or expressed. Sexuality is influenced by the 
interaction of biological, psychological, social, economic, 
political, cultural, legal, historical, religious, and spiritual 
factors (5).” This definition establishes two important 
things. First, the definition entails that sexuality is more 
than sexual intercourse alone. Therefore, it is imperative 
to make a distinction between sexual function (SF) and 
the quality of sexual life (QoSL). SF refers to the normal 
performance standards of the sexual response cycle (i.e., 
desire, excitement, orgasm, and resolution) (6,7). A sexual 
dysfunction is characterized by a disturbance in this sexual 
response cycle or by pain associated with intercourse (8). 
QoSL takes into account the person’s subjective evaluation 
of his/her SF and, thus, concerns the extent to which 
someone is (dis)satisfied. One may assume that if patients 
experience sexual dysfunction after colorectal cancer 
treatment they will also report a lower QoSL, since 
these concepts are related. However, patients may not be 
bothered with sexual dysfunction if they employ other 
ways to establish a satisfactory sexual relationship (2-4). 
For instance, couples coping with colorectal cancer stated 
that intimacy (e.g., hugging/kissing) is more important 
than being able to have sexual intercourse (6). On the other 
hand, patients may also report a low QoSL without an 
apparent sexual dysfunction (2-4). Secondly, the definition 
of sexuality shows that sexuality can be influenced by 
different factors, which warrants the need to evaluate sexual 
(dys)function and QoSL from a biopsychosocial perspective.
The current research on sexuality after colorectal cancer, 
however, is primarily focused on evaluating the levels of SF 
and treatment-related predictors of this SF. These studies 
show that multidisciplinary colorectal cancer treatment 
may influence patients’ SF (e.g., erectile or ejaculatory 
dysfunction in men and dyspareunia and lubrication 
problems in women). In addition, studies did found a 
significant relationship between SF and demographic 
factors [e.g., age (9,10), sex (11)], psychological issues [e.g., 
depressive or anxious symptoms (12), body image (13), 
fatigue (14)], and social aspects [e.g., social support (9)]. 
However, only one cross-sectional study examined SF 
using a biopsychosocial approach (i.e., incorporating all 
relevant variables in one study) (9). In this study, older 
age, having received an abdominoperineal resection, and 
poor social support were associated with low SF in men, 
while low SF in women was associated with higher age and 
poor global quality of life (9). Studies examining QoSL 
are scare. Currently, few studies reported that treatment-
related factors were related to sexual satisfaction and/or 
sexual enjoyment, however, no study has yet evaluated 
biopsychosocial predictors of QoSL (10). 
At present there is thus only limited information on 
biopsychosocial predictors of SF and QoSL in patients with 
colorectal cancer. Moreover, no study has yet evaluated to 
what extent SF and QoSL are related. Therefore, this study 
aimed to evaluate (I) relatedness between SF and QoSL, 
(II) the course of SF and QoSL, and (III) biopsychosocial 
predictors of SF and QoSL during the first year after 
colorectal cancer surgery. 
Methods
Participants
Data were drawn from a larger study examining the (sexual) 
consequences of colorectal cancer for patients and their 
partners (NCT01234246). For this study, both patients and 
partners were invited to participate. In addition, partners 
were still invited to participate even if patients declined 
participation and vice versa, in order to prevent selection 
bias. Patients and partners were recruited from six Dutch 
hospitals: St. Elisabeth hospital (Tilburg), TweeSteden 
Hospital (Tilburg and Waalwijk), Catharina Hospital 
(Eindhoven), Jeroen Bosch Hospital (‘s Hertogenbosch), 
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Amphia Hospital (Breda), and Maxima Medical Centre 
(Eindhoven and Veldhoven). To be eligible for participation, 
patients and partners had to be older than 18 years. Patients 
were excluded if one or more of the following criteria were 
applicable: (I) elderly age (>75 years), (II) non-curatively 
treated metastases at baseline, (III) poor expression of the 
Dutch language, (IV) dementia, and/or (V) a history of 
psychiatric illness. Partners with (I) insufficient knowledge 
of the Dutch language and (II) with dementia or a history of 
psychiatric illness were excluded. During a preoperative visit 
eligible patients and partners were asked, by their treating 
physician, if they gave permission to be approached by a 
member of the research team. Subsequently, this member 
contacted the potential participants by phone to explain 
the design and purpose of the study. If patients and/or 
partners agreed to participate they were asked to complete 
a set of questionnaires at home before surgery (Time-
0) and 3 (Time-1), 6 (Time-2), and 12 months (Time-3) 
postoperative. However, the Dutch guidelines recommend 
that all patients with rectal cancer, except those with a 
clinical T1 stage without positive lymph nodes, receive 
neoadjuvant treatments [i.e., radio(chemo)therapy; www.
oncoline.nl]. Therefore, a subset of patients and partners 
completed the first set of questionnaires prior to surgery, 
but potentially during or after the time patients received 
neoadjuvant therapy. Patients and partners returned the 
surveys in sealed postage-paid envelopes. Patients and 
partners who did not return the questionnaires within two 
weeks received reminders [phone call(s) and/or a reminder 
letter]. This study was approved by the institutional review 
board. All patients and partners gave written informed 
consent. As this specific study incorporated evaluating 
partner-related influences on the patients’ SF, only 
participating couples were included in the current sample. 
Measures
The patient’s clinical information was retrieved from the 
Eindhoven Cancer Registry (ECR). The ECR routinely 
collects data on tumor characteristics and treatment. If 
needed, additional clinical information was retrieved from 
the patient’s medical records. Patients also completed 
questions regarding their age, sex, and length of the 
relationship with their partner.
Two aspects of the patients’ personality were assessed. 
Neuroticism was assessed with the Neuroticism facet of 
the Neuroticism-Extraversion-Openness-Five Factor 
Inventory (NEO-FFI) (15). This factor assesses six aspects 
belonging to neuroticism (i.e., anxiety, hostility, depression, 
self-consciousness, impulsiveness, vulnerability to stress). Trait 
anxiety was evaluated with the Dutch short form trait scale 
of the Spielberger State-Trait Anxiety Inventory (STAI) (16). 
The trait anxiety scale describes how persons generally feel 
and conceives anxiety as a personality disposition (16). 
Patients’ psychological function was assessed with 
four constructs, specifically, body image, state anxiety, 
depressive symptoms, and fatigue. Body image was 
evaluated with the Body Image Scale (17,18). Depressive 
symptoms were evaluated with the 16-item version of the 
Center for Epidemiological Studies-Depression Scale 
(CES-D) (14). State anxiety was assessed with the short 
form (6-items) of the STAI state anxiety scale (19). State 
anxiety is a momentary emotional condition characterized 
by subjective feelings of apprehension and tension, and 
heightened autonomic nervous system activity and may thus 
vary in intensity and fluctuate over time (19). Fatigue was 
evaluated with the Fatigue Assessment Scale (FAS) (20). 
The FAS assessing perceived fatigue and exhaustion. NB: 
fatigue was in this study for clarity purposes seen as a 
psychological factor, even though we know that fatigue is a 
multidimensional construct encompassing both physical and 
psychological aspects.
Social characteristics (i.e., sexual activity, SF, non-sensuality, 
avoidance, non-communication, relationship adjustment) 
were completed by both patients and partners, except 
for sexual activity, which was only completed by patients. 
Patients’ sexual activity was assessed with the question 
‘To what extent where you sexually active (with/without 
sexual intercourse)?’ from the European Organization for 
Research and Treatment of Cancer (EORTC) disease specific 
ColoRectal 38 (QLQ-CR38) (21). QoSL was evaluated with 
the Sexual Activity facet of the World Health Organization 
Quality of Life assessment (WHOQOL-100) (22,23). 
This facet contains the following items: ‘How would 
you rate your sex life?’, ‘How well are your sexual needs 
fulfilled?’, ‘How satisfied are you with your sex life?’, and 
‘Are you bothered by any difficulties in your sex life?’ SF 
was evaluated with two sex-specific questionnaires. Men 
completed the Erectile Function, Orgasmic Function, and 
Sexual Desire domains of the International Index of Erectile 
Function (IIEF) (24,25). Women completed the Arousal, 
Lubrication, Orgasmic Function, Sexual Desire, and Sexual 
Pain domains of the Female SF Index (FSFI) (26,27). 
If needed, patients could indicate that an item was not 
applicable. For the IIEF the total score was computed as 
the sum of at least five items and, thus, up to five items 
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were person-mean imputed. For the FSFI, domain scores 
were obtained following the standard scoring instruction. 
The IIEF and FSFI total scores were transformed into 
standardized z-scores. The z-scores were subsequently 
combined to obtain one SF score. Next, patients and 
partners completed the Avoidance, Non-Communication, 
and Non-Sensuality domains of the Golombok-Rust 
Inventory of Sexual Satisfaction (GRISS) (28). The GRISS 
has separate versions for men and women; however, the 
Avoidance, Non-Communication, and Non-Sensuality 
domains are comparable for both sexes. Finally, relationship 
(mal)adjustment was assessed with the Marital (Mal)
adjustment scale of the Maudsley Marital Questionnaire 
(MMQ) (29-31). Sociodemographic factors and personality 
characteristics were assessed only at Time-0, while all other 
questionnaires were completed at each time point (Time-0-3). 
The psychometric properties of all questionnaires were 
satisfactory. 
Statistical analyses
An independent t-test and Chi-square tests were used to 
examine potential differences in age, sex, and type of tumor 
for participants and non-participants. Bivariate correlations 
between SF and QoSL were at each time point assessed 
with the Pearson correlation coefficient. Correlations 
were grouped into small (r≤0.30), moderate (r=0.30-0.49), 
or high (r>0.49) (32). Linear mixed-effects models with 
an unstructured error covariance pattern model were 
used to examine (I) the course of SF and QoSL and (II) 
predictors for both constructs. Time was analysed as a 
categorical predictor with four levels (i.e., Time-0, Time-1, 
Time-2, and Time-3). The fixed-effects parameters of 
the models were estimated with maximum likelihood. 
Sociodemographic variables (i.e., age, sex), clinical variables 
(i.e., tumor type, type of surgery, radiotherapy (yes/no), 
chemoradiation (yes/no), chemoradiation (yes/no), stoma 
(yes/no)), and personality characteristics (i.e., trait anxiety 
and neuroticism) were analysed as time-invariant predictors 
as they were only assessed at baseline. Psychological 
variables and symptoms (i.e., anxiety, depressive symptoms, 
body image, and fatigue), patient-related social variables (i.e., 
sexual activity, relationship adjustment, SF, non-sensuality, 
avoidance, non-communication), and partner-related 
social variables (i.e., SF, relationship adjustment, QoSL, 
non-sensuality, avoidance, non-communication), were 
measured at each time point and analysed as time-varying 
predictors (33). 
Analyses proceeded in three steps (method: forward). 
A basic set of predictors (i.e., age, sex, and type of tumor, 
Block 1) was formed to which, in separate analyses, a 
specific block of predictors was added. The following 
additional sets were formed: basic set + personality 
characteristics (Block 2), basic set + psychological variables 
(Block 3), basic set + patient-related social factors (Block 4), 
basic set + partner-related social factors (Block 5), and 
basic set + clinical characteristics (Block 6). These sets were 
formed based on content. To minimize data-driven choices 
and to identify the parsimonious model, a P<0.10 was 
used during the selection procedure. Second, the selected 
variables were analysed in one final model. If the effect of 
time-varying predictors was significant in the final model, 
then the effect was split into two effects in the second step 
of the analysis: between-subjects effects (e.g., the degree to 
which patients’ SF/QoSL is related to their average level on 
a predictor) and within-subjects effects (e.g., the degree to 
which variation in patients’ SF/QoSL over time is associated 
with a change in their levels on a predictor) (33). Finally, 
in the third step, the interaction between time and gender 
and time and type of tumor was evaluated in two separate 
modes, thus evaluating one interaction affect at a time, for 
both outcomes (i.e., SF and QoSL). In order to correctly 
interpret all model parameters, all time-varying variables 
have been grand-mean centered. Analyses were performed 
in IBM SPSS 19.0, using a significance level of P<0.05 (with 
exception of the selection procedure).
Results
Participants
In total, 672 eligible patients agreed to be contacted by 
a member of the research group, who informed them 
about the study. Of them, 313 (47%) patients agreed to 
participate; 64% of patients with rectal cancer participated 
and 50% of the patients with colon cancer participated 
(P=0.001). Fewer women (38%) than men (62%) were 
approached for this study. In addition, women less 
often participated (43%) than men (66%). Of the 313 
patients, 279 (89%) had a partner of which 206 (74%) 
participated. Since partner-related variables were taken 
into account, only couples were included in the analyses 
(n=206). An overview of the number of participants at each 
time point is provided in Table 1. In addition, patients’ 
time-invariant characteristics are presented in Table 2 while 
time-varying variables are presented in Table 3. 
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Relationship between SF and QoSL
At each time point a significant association was reported 
between SF and QoSL. At Time-0 a moderate correlation 
was reported (r=0.47, P=0.01), while at Time-1 a high 
association was noted (r=0.64, P=0.01). The correlation 
decreased at Time-2 (r=0.21, P=0.05), but subsequently 
increased to the baseline level at Time-3 (r=0.45, P=0.01).
Course and predictors of patients’ SF 
The selection procedure showed that a higher age (P=0.002, 
Block 1), having rectal cancer (P=0.001, Block 1), more 
anxiety (P=0.009, Block 3), more depressive symptoms 
(P=0.004, Block 3), more fatigue (P=0.001, Block 3), 
not being sexually active (P≤0.001, Block 4), more non-
sensuality (P=.006, Block 4), higher levels of partners’ SF 
(P≤0.001, Block 5), and not having a stoma (P=0.011, Block 
6) predicted the course and level of patients’ SF and were, 
therefore, included in the final model (Table 4, Part I). 
In the final model for SF, the effect of time was not 
significant. A higher age (β=−0.02, P=0.006), more fatigue 
(β=−0.02, P=.034), no sexual activity (β=−0.81, P<0.001), 
higher partners’ SF (β=0.24, P<0.001), and having a stoma 
(β=0.24, P=0.035) contributed significantly to patients’ 
lower SF. 
For the abovementioned significant time-varying 
predictors, the between- and within-subject analyses showed 
that patients who on average reported not to be sexually 
active had on average lower levels of SF (between-subjects 
effect, β=1.03, P<0.001, Table 4, Part II). Moreover, patients 
that showed a positive change in sexual activity on a time 
point also showed a positive change in SF (within-subjects 
effect, β=0.62, P=0.001). Patients that on average were 
more tired scored on average lower on SF (between-subjects 
effect, β=−0.03, P=0.012). Finally, if the partners reported 
on average higher SF this predicted on average better SF 
for the patients (between-subjects effect, β=0.32, P=0.001). 
The within-subject effects for fatigue and the partners’ SF 
were not significant. 
Finally, there was a significant interaction effect between 
time and gender (P=0.002, see Figure 1A and Table 4, Part 
III). Overall, the scores on SF fluctuated across time, but 
the difference between men and women was only significant 
at Time-1. Women reported low SF at Time-0 and showed 
a large increase at Time-1. Men scored average on Time-0, 
Time-2 and Time-3 but showed a decrease at Time-1. 
Only at Time-1 women reported a significantly higher SF. 
At Time-2 and Time-3 the SF scores were very similar for 
women and men. The interaction between time and type of 
tumor was not significant (results not shown). 
Course and predictors of patients’ QoSL
The selection procedure showed that having rectal cancer 
(P<0.001, Block 1), higher levels of neuroticism (P=0.037, 
Block 2), more depressive symptoms (P=0.003, Block 3), 
lower body image (P=0.019, Block 3), better SF (P<0.001, 
Block 4), better relationship adjustment (P=0.001, Block 4), 
more avoidance (P=0.009, Block 4), better partners’ SF 
(P=0.005, Block 5), higher partners’ QoSL (P<0.001, Block 5), 
and not having a stoma (P=0.020, Block 6) predicted the 
course and levels of QoSL. 
The EMM of the final model showed that QoSL at 
Time-0 was 14.5 which decreased 1.4 points to 13.1 at 
Time-1, then decreased a little further to 12.1 at Time-2, 
Table 1 Number of participants at each assessment point
Assessment point
Time-0 Time-1 Time-2 Time-3
Patients Partners Patients Partners Patients Partners Patients Partners
Completed the assessment point 164 166 148 141 123 114 104 89
Participated from Time-1 onwards  
(i.e., Time-0 = missing)
42 40
Did not complete the assessment 10 10 14 14 3 7
Dropped-out at Time-1 23 28 23 28 23 28
Dropped-out at Time-2 11 15 11 15
Dropped-out at Time-3 16 18
Not yet completed the assessment point* 25 27 35 35 49 49
*, due to the ongoing nature of the study not all participants had already completed all time points.
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and finally increased slightly to an EMM of 13.3 at Time-3 
(P<0.001, Table 5, Part I). In this model, having rectal cancer 
(β=−1.64, P=0.003), more depressive symptoms (β=−0.09, 
P=0.001), lower SF (β=1.05, P<0.001), more relationship 
(mal)adjustment (β=-0.05, P=0.027), and lower partners’ 
QoSL (β=0.30, P<0.001) contributed significantly to a lower 
QoSL for the patients (P<0.05). 
The between- and within-subjects analyses (Table 5, Part II), 
showed that patients with more depressive symptoms or 
higher relationship maladjustment on a time point also 
reported a negative change in QoSL on that time point 
[within-subject effects, β=−0.11 (P=0.009) and β=−0.07 
(P=0.047), respectively]. Patients who on average reported 
a lower SF had on average lower levels of QoSL (between-
subjects effect, β=1.36, P<0.001). Moreover, patients who 
showed change in SF on a time point also showed a change 
in the QoSL (within-subjects effect, β=0.67, P=0.039). If 
partners on average reported higher QoSL then patients, 
on average, also scored higher on QoSL (between-subjects 
effect, β=0.30, P=0.001). Also, if partners changed in their 
QoSL, then patients’ QoSL also changed (within-subjects 
effect, β=0.30, P=0.001). 
The interaction between time and gender was significant 
(P=0.002, see Figure 1B and Table 5, Part III). Compared 
with Time-1, women showed lower but comparable 
QoSL scores at the subsequent time points. However, 
the pattern for men differed. Men’s QoSL decreased at 
Time-1 and continued to drop at Time-2, but finally 
increased somewhat at Time-3. At Time-0, women had a 
significantly higher QoSL then men (P=0.002, EMM=16.3 
and 13.9, respectively). In addition, men scored significantly 
lower (EMM=11.7) than women (EMM=13.1) at Time-2 
(P=0.035). Again, the interaction between time and type of 
tumor was not significant (results not shown).
Discussion
Compared to the preoperative scores, patients’ SF did not 
change significantly during the first year after surgery. 
However, the course of patients’ QoSL did change. 
Compared with the preoperative assessment, patients’ QoSL 
was significantly lower at 3, 6, and 12 months postoperative. 
Evaluating biopsychosocial predictors of patients’ SF 
and QoSL revealed that a higher age and having a stoma 
contributed to lower scores on SF, but did not contribute to 
QoSL. The association between sexual dysfunction and a 
higher age (9,10,34) and having a stoma (11,35-37) has been 
previously reported. Furthermore, patients who on average 
were more tired scored on average lower on SF, but this 
association was not found for the QoSL. This result is in 
line with a previous cross-sectional among colorectal cancer 
survivors (14). Moreover, anxiety and depressive symptoms 
did not predict SF, but depressive symptoms on a time point 
did predict a negative change in QoSL on that time point. In 
Table 2 Descriptives for the time-invariant predictors
Characteristics Patients (n=205)
Age at time of survey (mean ± SD) 62.0±8.6
Relationship in years (mean ± SD) 35.9±16.3
Neuroticism 27.1±6.7
Trait anxiety 16.6±4.8
Male gender, N (%) 146 (71.2)
Type of cancer, N (%)
Colon 125 (61.0)
Rectum 80 (39.0)
Type of surgery, N (%)
Low anterior resection 84 (41.0)
Abdominoperineal resection 35 (17.1)
Hemicolectomy/ileocecal resection 29 (14.1)
Sigmoid resection 27 (13.2)
Other 27 (13.2)
Unknown type of surgery 3 (1.5)
Type of radiotherapy (RT), N (%)
No RT 135 (65.9)
Preoperative RT 42 (20.5)
Intra-Operative RT 19 (9.3)






Type of chemotherapy (CT), N (%)
No CT 145 (70.7)
Postoperative CT 50 (24.4)






Neuroticism range, 12-60; trait anxiety range, 10-40.
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previous research, results are mixed. Milbury et al. 2013 (7) 
did not find a significant association between depressive 
symptoms and SF, while depressive symptoms were 
associated with both SF and sexual enjoyment in the study 
of Den Oudsten et al. 2012 (14). Therefore, more research 
examining the relationship between depressive symptoms 
and SF and QoSL is still needed. 
Several observations regarding the relatedness between 
SF and QoSL can be made. Patients that on average 
reported a lower SF had on average lower levels of QoSL 
and a change in SF on a time point also predicted a change 
in QoSL at the that time point. This finding supports the 
idea that the constructs SF and QoSL are inter-related. 
However, a high correlation between SF and QoSL was only 
reported at Time-1. Thus, even though these concepts are 
related, they may be best viewed as separate constructs. The 
distinction between both constructs is further supported 
by the fact that different predictors were found for the 
QoSL and SF (see above). Finally, this study indicates 
that SF, relationship (mal)adjustment, and QoSL can be 
conceptualized as constructs ranging from narrow to broad: 
Being sexually active (with or without sexual intercourse) 
was both between- and within-subjects associated with SF, 
but not with the QoSL. Additionally, higher relationship 
maladjustment on a time point predicted a negative change 
in QoSL on that time point, but relationship maladjustment 
did not predict SF. 
Another interesting finding is that partners’ SF and QoSL 
were predictive for patients’ SF and QoSL, respectively. 
Therefore, interdependence between patients and partners 
Table 3 Descriptives for the time-varying predictors 
Predictors Time-0 (M ± SD) Time-1 (M ± SD) Time-2 (M ± SD) Time-3 (M ± SD)
QoSL (WHOQOL-100)
Patients 13.4±3.6 12.1±3.6 12.1±6.0 12.5±3.9
Partners 13.6±3.4 12.1±3.2 12.1±3.3 12.4±3.4
Relationship (mal)adjustment (MMQ)
Patients 13.3±7.2 13.7±9.2 14.7±8.4 14.9±8.4
Partners 14.5±8.2 15.7±8.5 16.0±8.9 15.8±10.3
SF (z-score)
Patients −2.5±1.0 −2.1±1.0 −1.3±1.0 −1.4±1.0
Partners −2.4±1.0 −1.7±1.0 −1.3±1.0 −1.3±1.0
Non-sensuality (GRISS)
Patients 6.4±2.9 7.1±2.8 7.3±3.2 7.1±3.1
Avoidance (GRISS)
Patients 5.3±2.6 5.8±2.8 5.8±2.5 5.7±2.7
Non-communication (GRISS)
Patients 5.1±1.8 5.6±2.8 5.2±1.8 5.2±1.9
Depressive symptoms (CES-D)
Patients 5.9±6.7 5.64±5.6 5.8±6.5 4.8±6.1
Body image (BIS)
Patients 24.5±13.4 18.7±8.3 17.8±7.2 18.5±8.0
Fatigue (FAS)
Patients 19.5±5.7 22.2±6.6 21.8±7.1 20.3±6.3
Higher scores indicate more problems, except for the QoSL and SF domains. For these domains higher scores indicate a higher 
QoSL or SF, respectively. Time-0, preoperative measurement; Time-1, 3 months follow-up; Time-2, 6 months follow-up; Time-3, 
12 months follow-up; BIS, body image scale (range, 10-40); CES-D, center for epidemiological studies-depression scale (range, 
0-48); FAS, fatigue assessment scale (range, 10-50); GRISS, golombok-rust inventory of sexual satisfaction; MMQ, maudsley 
marital questionnaire (range, 0-80); QoSL, quality of sexual life; SF, sexual function; STAI, Spielberger state-trait anxiety inventory 
(range, 4-24); WHOQOL-100, World Health Organization Quality of Life assessment (range, 4-20). 
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seems present. While previous research has already 
addressed the importance of evaluating and addressing the 
consequences of cancer from a couple-based perspective 
(38,39), this is the first study that incorporated partner-
related variables as predictors for patients’ SF and QoSL.
Few clinical variables were significant predictors of 
patients’ SF and QoSL. Not having a stoma was predictive 
for better SF while having rectal cancer predicted a lower 
QoSL. The lack of other significant clinical predictors 
may seem remarkable as earlier studies have shown that 
radiotherapy (11,40,41), but especially surgical nerve 
damage (which can be roughly estimated based on type of 
surgery) seems to play an important role in the occurrence 
of sexual dysfunction (38). However, type and location of 
the tumor leads to a protocolled treatment schedule. The 
high correlation between the treatment related variables 
Table 4 Estimates of fixed effects for SF
Predictora B SE Sig.
95% CI
Lower bound Upper bound
Part I
Timeb 0.093
Time-0 (intercept) 0.05 0.23 0.838 −0.41 0.50
Time-1-Time-0 −0.04 0.16 0.815 −0.36 0.28
Time-2-Time-0 0.22 0.15 0.164 −0.09 0.52
Time-3-Time-0 0.29 0.16 0.070 −0.02 0.59
Age −0.02 0.01 0.006* −0.04 −0.01
Male gender −0.05 0.13 0.731 −0.31 0.22
Having rectal cancer −0.12 0.17 0.474 −0.46 0.22
Anxiety −0.01 0.02 0.626 −0.05 0.03
Depressive symptoms 0.01 0.01 0.505 −0.01 0.03
Fatigue −0.02 0.01 0.034* −0.04 0.00
Not being sexual active −0.81 0.15 <0.001* −1.11 −0.51
Non-sensuality −0.04 0.02 0.065 −0.08 0.00
Not having a stoma 0.37 0.17 0.035* 0.03 0.71
Partners SF 0.24 0.07 <0.001* 0.10 0.38
Part II
Fatigue: between −0.03 0.01 0.012* −0.06 −0.01
Fatigue: within −0.01 0.01 0.548 −0.03 0.02
Not being sexual active: between 1.03 0.22 <0.001* 0.60 1.46
Not being sexual active: within 0.62 0.18 0.001* 0.25 0.98
Partners’ SF: between 0.32 0.09 0.001* 0.14 0.49
Partners’ SF: within 0.16 0.09 0.099 −0.03 0.34
Part III
Interaction effect Sex*Timeb 0.002*
Sex at Time-0 0.53 0.27 0.054 −0.01 1.06
Sex at Time-1c −0.61 0.22 0.005* −1.04 −0.19
Sex at Time-2c 0.11 0.17 0.519 −0.23 0.46
Sex at Time-3c −0.157 0.19 0.427 −0.52 0.22
a, all predictors (except Time) are grand-mean centered; b, analysis of variance (ANOVA) type III test; c, post-hoc test of simple 
effects; *, statistically significant results (P<0.05). Time-0, preoperative measurement; Time-1, 3 months follow-up; Time-2, 
6 months follow-up; Time-3, 12 months follow-up.
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makes it difficult to find significant unique effects of each 
variable separately, especially since the number of patients 
included in the analyses was limited. 
An important methodological consideration that needs 
to be acknowledged concerns the questionnaires used in the 
current study. While validated and reliable questionnaires 
were used, a difficulty lied in obtaining one SF score 
(regardless of gender). For men, aspects such as erectile 
and ejaculatory (dys)function were measured while women 
answered questions regarding problems with lubrication or 
pain during intercourse. Therefore, sex-specific sum scores 
were transformed into z-scores and combined in one SF 
score. This resulted in a loss of information. Unfortunately, 
it was not possible to evaluate the specific effects of each 
SF domain on the QoSL for men and women separately, 
due to a limited sample size. However, the significant 
interaction between time and gender showed that the SF 
and QoSL trajectories are different for men and women. 
Therefore, future more in-depth studies in this area are still 
warranted. Another limitation concerns the generalizability 
of the results. Since evaluating partner-related predictors 
of the patient’s SF and QoSL was part of the current study, 
only couples were included. However, sexuality is not 
only an issue for couples. Future research is, therefore, 
needed to evaluate biological and psychological predictors 
of SF and QoSL for single or widowed patients. The fact 
that all couples were in a heterosexual relationship is also 
unfortunate, as this was not a prerequisite for participation. 
Future studies are encouraged to include couples/patients 
with non-heterosexual orientations (e.g., gay, lesbian, or 
bisexual). Moreover, only information on the patient’s sexual 
activity (with or without sexual intercourse) was available. 
This is regrettable as the patient’s sexual activity status is 
not necessarily similar to the sexual activity status of the 
partner, due to possible sole or external sexual activities 
outside the nominated relationship. In addition, based on 
this question it was not possible to determine what type 
of sexual activities patients engaged in. For both patients 
and partners, more insight into what constitutes as sexual 
activity is still needed. Finally, this study did not evaluate 
biopsychosocial predictors of the partners’ SF and QoSL, 
nor did this study evaluate the dynamics between patients 
and partners in depth. Future studies are encouraged to 
address these topics.
Regardless of the abovementioned methodological 
considerations, the results show that not only clinical but 
also psychosocial factors play a role in patients’ SF and 
QoSL. Therefore, it is stimulated that clinicians address 
this issue during treatment. In addition, it is favored 
that clinicians focus not only on biological damage after 
treatment, but obtain a broader perspective in which they 
also pay attention to psychosocial factors that may impair 
SF and QoSL. Finally, the interdependence between 
patients and partners is imperative and entails that both 
in research and clinical practice should be attentive to the 
couple and may best perceive cancer as a ‘we-disease’ (42). 
Regardless of the abovementioned methodological 
considerations, the results show that SF and QoSL are 
related but distinctive constructs, for which different 
biopsychosocial predictors were identified. In addition, SF 
did not change significantly over time, while the QoSL 
decreased from Time-0 to Time-1 and Time-2 and finally 
increased somewhat at Time-3. Discussing SF and QoSL has 
been found to be an important topic for both patients and 
partners (43,44). When discussing sexuality, it is important 
to realize that SF and QoSL are no interchangeable terms 
and they should, therefore, be discussed as two separate 
entities. In addition, it is favored that clinicians focus not 
only on biological predictors of SF and QoSL, but that they 
obtain a broader perspective in which they also pay attention 
to psychosocial factors that may impair SF and QoSL. 
The significant contribution of partners’ SF and QoSL to 
Figure 1 Interaction effect between time and gender for quality of sexual life and sexual function. 
Interaction effect between time and gender for quality of sexual life
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Table 5 Estimates of fixed effects for QoSL
Predictora B SE Sig.
95% CI
Lower bound Upper bound
Part I
Timeb <0.001*
Time-0 (intercept) 15.78 0.68 <0.001* 14.42 17.13
Time-1-Time-0 −1.44 0.43 0.003* −2.31 −0.56
Time-2-Time-0 −2.38 0.50 <0.001* −3.38 −1.37
Time-3-Time-0 −1.41 0.45 0.002* −2.32 −0.49
Age 0.02 0.02 0.377 −0.03 0.07
Male gender −0.78 0.42 0.066 −1.61 0.05
Having rectal cancer −1.64 0.53 0.003* −2.70 −0.58
Neuroticism −0.03 0.03 0.391 −0.09 0.04
Depressive symptoms −0.09 0.03 0.001* −0.15 −0.04
Body image −0.05 0.03 0.081 −0.11 0.01
SF 1.05 0.22 <0.000* 0.61 1.48
Relationship maladjustment −0.05 0.02 0.027* −0.09 −0.01
Avoidance −0.04 0.08 0.670 −0.20 0.13
Partners’ SF 0.20 0.24 0.392 −0.26 0.67
Partners’ QoSL 0.30 0.06 <0.001* 0.17 0.43
Not having a stoma −0.12 0.53 0.815 −1.17 0.93
Part II
Depressive symptoms: between −0.08 0.04 0.073 −0.02 0.01
Depressive symptoms: within −0.11 0.04 0.009* −0.18 −0.03
SF: between 1.36 0.28 <0.001* 0.79 1.92
SF: within 0.67 0.31 0.039* 0.03 1.28
Relationship maladjustment: between −0.03 0.03 0.232 −0.09 0.02
Relationship maladjustment: within −0.07 0.04 0.047* −0.14 −0.00
Partners’ QoSL: between 0.30 0.08 0.001* 0.13 0.47
Partners’ QoSL: within 0.30 0.09 0.001* 0.12 0.49
Part III
Interaction effect Sex*Timeb 0.002*
Sex at Time-0 −2.37 0.69 0.002* −3.78 −0.95
Sex at Time-1c 0.63 0.61 0.301 −0.59 1.85
Sex at Time-2c −1.36 0.63 0.035* −2.62 −0.10
Sex at Time-3c 0.73 0.89 0.411 −1.03 2.48
a, all continuous predictors (except Time) are grand-mean centered; b, analysis of variance (ANOVA) type III test; c, post-hoc test of 
simple effects; *, statistically significant results (P<0.05). Time-0, preoperative measurement; Time-1, 3 months follow-up; Time-2, 
6 months follow-up; Time-3, 12 months follow-up. QoSL, quality of sexual life.
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patients’ SF and QoSL suggests interdependence between 
patients and partners. However, future research is needed 
to entail more insight in the dynamic between patients and 
partners. In addition, studies focussing specifically on the 
partner and studies that include single of widowed patients 
are still warranted. Finally, the significant interaction between 
time and gender suggest that SF and QoSL trajectories differ 
for men and women. Future research is needed in order to 
evaluate gender effects and interdependence between patients 
and partners more in depth. 
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